Aytu BioScience (AYTU) has shared an announcement.
Aytu BioPharma has announced the sale of its Consumer Health business, marking the completion of its strategy to wind down operations in this sector. The details of the sale are outlined in a press release, which has been publicly shared but is not considered part of the company’s formal legal filings with the Securities and Exchange Commission.
Find detailed analytics on AYTU stock on TipRanks’ Stock Analysis page.
